Literature DB >> 9811345

Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy.

J Wang1, H Zheng, C C Sung, K K Richter, M Hauer-Jensen.   

Abstract

The three mammalian transforming growth factor (TGF)-beta isoforms (TGF-beta1, TGF-beta2, and TGF-beta3) differ in their putative roles in radiation-induced fibrosis in intestine and other organs. Furthermore, tissue specificity of TGF-beta action may result from temporal or spatial changes in production and/or activation. The present study examined shifts in the cell types expressing TGF-beta mRNA relative to TGF-beta immunoreactivity and histopathological injury during radiation enteropathy development. A 4-cm loop of rat small intestine was locally exposed to O, 12, or 21-Gy single doses of x-irradiation. Sham-irradiated and irradiated intestine were procured 2 and 26 weeks after irradiation. Cells expressing the TGF-beta1, TGF-beta2, or TGF-beta3 transcripts were identified by in situ hybridization with digoxigenin-labeled riboprobes. Intestinal wall TGF-beta immunoreactivity was measured using computerized image analysis, and structural radiation injury was assessed by quantitative histopathology. Normal intestinal epithelium expressed transcripts for all three TGF-beta isoforms. Two weeks after irradiation, regenerating crypts, inflammatory cells, smooth muscle cells, and mesothelium exhibited increased TGF-beta1 expression and, to a lesser degree, TGF-beta2 and TGF-beta3 expression. Twenty-six weeks after irradiation, TGF-beta2 and TGF-beta3 expression had returned to normal. In contrast, TGF-beta1 expression remained elevated in smooth muscle, mesothelium, endothelium, and fibroblasts in regions of chronic fibrosis. Extracellular matrix-associated TGF-beta1 immunoreactivity was significantly increased at both observation times, whereas, TGF-beta2 and TGF-beta3 immunoreactivity exhibited minimal postradiation changes. Intestinal radiation injury is associated with overexpression of all three TGF-beta isoforms in regenerating epithelium. Radiation enteropathy was also associated with sustained shifts in the cellular sources of TGF-beta1 from epithelial cells to cells involved in the pathogenesis of chronic fibrosis. TGF-beta2 and TGF-beta3 did not exhibit consistent long-term changes. TGF-beta1 appears to be the predominant isoform in radiation enteropathy and may be more important in the mechanisms of chronicity than TGF-beta2 and TGF-beta3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811345      PMCID: PMC1853410          DOI: 10.1016/s0002-9440(10)65741-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  Differential influence of TGFbeta1 and TGFbeta3 isoforms on cell cycle kinetics and postirradiation recovery of normal and malignant colorectal epithelial cells.

Authors:  H Robson; K Spence; E Anderson; C S Potten; J H Hendry
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-04-01       Impact factor: 7.038

2.  Increased transforming growth factor beta (TGF-beta) immunoreactivity is independently associated with chronic injury in both consequential and primary radiation enteropathy.

Authors:  K K Richter; C W Langberg; C C Sung; M Hauer-Jensen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-08-01       Impact factor: 7.038

3.  Regulation of intestinal epithelial cell growth by transforming growth factor type beta.

Authors:  J A Barnard; R D Beauchamp; R J Coffey; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

4.  Radiation-induced alteration of rat mesangial cell transforming growth factor-beta and expression of the genes associated with the extracellular matrix.

Authors:  J Wang; M E Robbins
Journal:  Radiat Res       Date:  1996-11       Impact factor: 2.841

5.  Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis.

Authors:  R K Coker; G J Laurent; S Shahzeidi; P A Lympany; R M du Bois; P K Jeffery; R J McAnulty
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

6.  Spatial and temporal patterns of expression of epidermal growth factor, transforming growth factor alpha and transforming growth factor beta 1-3 and their receptors in mouse jejunum after radiation treatment.

Authors:  A C Ruifrok; K A Mason; G Lozano; H D Thames
Journal:  Radiat Res       Date:  1997-01       Impact factor: 2.841

7.  Is the loss of endothelial thrombomodulin involved in the mechanism of chronicity in late radiation enteropathy?

Authors:  K K Richter; L M Fink; B M Hughes; C C Sung; M Hauer-Jensen
Journal:  Radiother Oncol       Date:  1997-07       Impact factor: 6.280

8.  Differential expression of transforming growth factors alpha and beta in rat intestinal epithelial cells.

Authors:  S Y Koyama; D K Podolsky
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

9.  Changes in transforming growth factor beta1 gene expression and immunoreactivity levels during development of chronic radiation enteropathy.

Authors:  M Hauer-Jensen; K K Richter; J Wang; E Abe; C C Sung; J W Hardin
Journal:  Radiat Res       Date:  1998-12       Impact factor: 2.841

10.  Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos.

Authors:  D A Miller; A Lee; R W Pelton; E Y Chen; H L Moses; R Derynck
Journal:  Mol Endocrinol       Date:  1989-07
View more
  31 in total

1.  Influence of sublethal total-body irradiation on immune cell populations in the intestinal mucosa.

Authors:  Sarita Garg; Marjan Boerma; Junru Wang; Qiang Fu; David S Loose; K Sree Kumar; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

2.  Neoadjuvant radiochemotherapy for patients with locally advanced rectal cancer leads to impairment of the anal sphincter.

Authors:  Joerg Theisen; Werner K-H Kauer; Hjalmar Nekarda; Ludwig Schmid; Hubert J Stein; Joerg-Ruediger Siewert
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

Review 3.  Radiotherapy and wound healing.

Authors:  Emma-Louise Dormand; Paul E Banwell; Timothy E E Goodacre
Journal:  Int Wound J       Date:  2005-06       Impact factor: 3.315

4.  Mast cells are an essential component of human radiation proctitis and contribute to experimental colorectal damage in mice.

Authors:  Karl Blirando; Fabien Milliat; Isabelle Martelly; Jean-Christophe Sabourin; Marc Benderitter; Agnès François
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 5.  Radiotherapy and wound healing.

Authors:  Haresh L Devalia; Lucy Mansfield
Journal:  Int Wound J       Date:  2007-12-12       Impact factor: 3.315

6.  Expression of matrix metalloproteinases and tissue inhibitor metalloproteinases increases in X-irradiated rat ileum despite the disappearance of CD8a T cells.

Authors:  Carine Strup-Perrot; Marie-Catherine Vozenin-Brotons; Marie Vandamme; Christine Linard; Denis Mathé
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

7.  Bone marrow transplantation helps restore the intestinal mucosal barrier after total body irradiation in mice.

Authors:  Sarita Garg; Wenze Wang; Biju G Prabath; Marjan Boerma; Junru Wang; Daohong Zhou; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2014-02-25       Impact factor: 2.841

8.  Smad3 knock-out mice as a useful model to study intestinal fibrogenesis.

Authors:  Giuliana Zanninelli; Antonella Vetuschi; Roberta Sferra; Angela D'Angelo; Amato Fratticci; Maria Adelaide Continenza; Maria Chiaramonte; Eugenio Gaudio; Renzo Caprilli; Giovanni Latella
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

9.  Influence of endothelin 1 receptor inhibition on functional, structural and molecular changes in the rat heart after irradiation.

Authors:  Marjan Boerma; Junru Wang; Ashwini Kulkarni; Kerrey A Roberto; Xiaohua Qiu; Richard H Kennedy; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2008-09       Impact factor: 2.841

10.  Essential role of plasminogen activator inhibitor type-1 in radiation enteropathy.

Authors:  Fabien Milliat; Jean-Christophe Sabourin; Georges Tarlet; Valerie Holler; Eric Deutsch; Valérie Buard; Radia Tamarat; Azeddine Atfi; Marc Benderitter; Agnès François
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.